These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1538636)

  • 1. Mathematical modeling or waiting decades for an empirical answer?
    Djulbegovic B; Woodcock TM
    Med Decis Making; 1992; 12(1):77. PubMed ID: 1538636
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for early-stage diffuse large-B-cell lymphoma.
    Friedberg JW
    Lancet Oncol; 2006 May; 7(5):357-9. PubMed ID: 16648037
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffuse large-cell lymphoma. Part II: management.
    García-Pallas MV; Betancourt-García RD; Pacheco E; Castro J; Cabanillas F
    P R Health Sci J; 2009 Mar; 28(1):12-7. PubMed ID: 19266734
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of non-Hodgkin's lymphoma in the elderly.
    Zagonel V; Tirelli U; Carbone A
    J Clin Oncol; 1986 Dec; 4(12):1866-7. PubMed ID: 3537220
    [No Abstract]   [Full Text] [Related]  

  • 6. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
    Wannesson L; Zucca E
    Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
    [No Abstract]   [Full Text] [Related]  

  • 7. Better right than quick?
    Stockler M
    Med Decis Making; 1992; 12(1):76-7. PubMed ID: 1538635
    [No Abstract]   [Full Text] [Related]  

  • 8. Is CHOP the standard of therapy for poor-prognosis large-cell lymphoma?
    Canellos GP
    Ann Oncol; 1997; 8 Suppl 1():61-2. PubMed ID: 9187432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Malignant lymphoma].
    Mori T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):162-6. PubMed ID: 17301521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.
    Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B
    Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpretation of clinical trials in diffuse large-cell lymphoma.
    Armitage JO; Cheson BD
    J Clin Oncol; 1988 Aug; 6(8):1335-47. PubMed ID: 3045267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced DLBCL: as systemic therapy improves, the need for RT diminishes.
    Canellos GP
    Oncology (Williston Park); 2014 Dec; 28(12):1085-6. PubMed ID: 25510807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of reticulosarcomas. Results of a controlled trial on 60 patients].
    Chauvergne J; Hoerni B; Durand M; Hoerni-Simon G; Lagarde C
    Nouv Presse Med; 1973 Sep; 2(31):2039-42. PubMed ID: 4581185
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma.
    Habermann TM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
    [No Abstract]   [Full Text] [Related]  

  • 15. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?
    Siegal T; Goldschmidt N
    Blood Rev; 2012 May; 26(3):97-106. PubMed ID: 22244544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)].
    Kinoshita T
    Rinsho Ketsueki; 2012 Feb; 53(2):145-54. PubMed ID: 22450573
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
    Sonet A; Bosly A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas.
    Jacobs EM; Peters FC; Luce JK; Zippin C; Wood DA
    JAMA; 1968 Feb; 203(6):392-8. PubMed ID: 4865234
    [No Abstract]   [Full Text] [Related]  

  • 20. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
    Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D
    J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.